COVID-19 is less serious in children than in adults. However, respiratory management dominates the clinical picture of hospitalized COVID-19 even in children. In some case series, deterioration of the clinical picture wherein dyspnea, cyanosis, and the onset of acute respiratory distress syndrome (ARDS) emerged ~8–10 days after the onset of SARS-CoV-2 infection, which could rapidly progress to multiple organ failure and death. This review aimed to evaluate the characteristics of COVID-19 pneumonia in pediatric populations, beginning from its etiology and pathological mechanisms and closing with its clinical management.
All Keywords
【저자키워드】 COVID-19, Treatment, SARS-CoV2, Pneumonia, children, 【초록키워드】 ARDS, SARS-COV-2 infection, pediatric, Adults, Deterioration, Case series, Characteristics, clinical picture, management, Dyspnea, death, Clinical management, multiple organ failure, etiology, acute respiratory distress, in some, syndrome, hospitalized COVID-19, Cyanosis, populations, pathological mechanism, evaluate, less,
【저자키워드】 COVID-19, Treatment, SARS-CoV2, Pneumonia, children, 【초록키워드】 ARDS, SARS-COV-2 infection, pediatric, Adults, Deterioration, Case series, Characteristics, clinical picture, management, Dyspnea, death, Clinical management, multiple organ failure, etiology, acute respiratory distress, in some, syndrome, hospitalized COVID-19, Cyanosis, populations, pathological mechanism, evaluate, less,